Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
25 results
D1.64 - Distinct and Overlapping Sensitization Patterns to Crustacean and House Dust Mite Allergens in Tropical Allergy
D1.72 - Assessing potential influencing factors on allergic reaction to the cumulative dose given on an extra day within oral food challenge in food-allergic children
D1.75 - Association of SCORAD Values with Skin Barrier Function Indicators in Patients with Atopic Dermatitis
D1.61 - Shrimp Tropomyosin as a Selective Allergen in a Case of Food Allergy: The Value of Individualized Molecular Analysis
D1.62 - Thermal stress alters the allergen and proteome profile of the redclaw crayfish (Cherax quadicarinatus)
D1.63 - Suspected Hypersensitivity to Non-Nutritive Sweeteners With Recurrent Respiratory Manifestations in a Pediatric Patient
D1.65 - Selective Allergy to Large Prawn: Identification of a Projectin-Derived IgE-Binding Protein
D1.66 - Allergy profiling in selective goat and sheep milk allergy
D1.67 - Comparison of machine learning models for grass carp allergy diagnosis
D1.70 - IgE-sensitization to allergens in plant-based drinks in children with cow’s milk allergy
D1.71 - Can an allergist predict the development of allergies? A Clinical case of dizygotic twins with divergent outcomes
D1.73 - Date Palm or Grass pollen rhinoconjuctivitis in a patient with watermelon allergy?
D1.74 - Sunflower Seed–Induced Anaphylaxis: Allergenic Characterization and Evidence of Cross-Reactivity with Niger Seeds
D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study
D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study
D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study
D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial
D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial
D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial
D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download